DK0753300T3 - Anvendelse af steroider med antioxidative egenskaber til fremstilling af farmaceutiske præparater til medikamentøs substitu - Google Patents

Anvendelse af steroider med antioxidative egenskaber til fremstilling af farmaceutiske præparater til medikamentøs substitu

Info

Publication number
DK0753300T3
DK0753300T3 DK96110339T DK96110339T DK0753300T3 DK 0753300 T3 DK0753300 T3 DK 0753300T3 DK 96110339 T DK96110339 T DK 96110339T DK 96110339 T DK96110339 T DK 96110339T DK 0753300 T3 DK0753300 T3 DK 0753300T3
Authority
DK
Denmark
Prior art keywords
steroids
substitutes
medicinal
preparation
antioxidant properties
Prior art date
Application number
DK96110339T
Other languages
English (en)
Inventor
Michael Prof Dr Oettel
Wolfgang Prof Dr Roemer
Doris Dr Huebler
Jens Schroeder
Sigfrid Prof Dr Schwarz
Peter Dr Droescher
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Application granted granted Critical
Publication of DK0753300T3 publication Critical patent/DK0753300T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96110339T 1995-07-08 1996-06-27 Anvendelse af steroider med antioxidative egenskaber til fremstilling af farmaceutiske præparater til medikamentøs substitu DK0753300T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19524937A DE19524937A1 (de) 1995-07-08 1995-07-08 Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen und zur medikamentösen Substitution beim Mann

Publications (1)

Publication Number Publication Date
DK0753300T3 true DK0753300T3 (da) 2000-03-27

Family

ID=7766353

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96110339T DK0753300T3 (da) 1995-07-08 1996-06-27 Anvendelse af steroider med antioxidative egenskaber til fremstilling af farmaceutiske præparater til medikamentøs substitu

Country Status (7)

Country Link
EP (1) EP0753300B1 (da)
JP (1) JP2765822B2 (da)
AT (1) ATE184795T1 (da)
DE (2) DE19524937A1 (da)
DK (1) DK0753300T3 (da)
ES (1) ES2138272T3 (da)
GR (1) GR3032191T3 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877169A (en) * 1993-11-05 1999-03-02 University Of Florida Research Foundation, Inc. Methods of treatment of ischemic damage
AU739071C (en) * 1998-02-20 2002-04-11 Jenapharm Gmbh & Co. Kg Pharmaceutical preparations for the selectively supplementing estrogen deficiency in the central nervous system
DE19821831A1 (de) * 1998-05-15 1999-11-18 Jenapharm Gmbh Pharmazeutische Präparate zur gezielten Substitution des Estrogenmangels im Zentralnervensystem
US6245756B1 (en) 1998-02-27 2001-06-12 Jenapharm Gmbh & Co. Kg Pharmaceutical preparations for treatment of estrogen deficiency in the central nervous system
DE19915576A1 (de) * 1999-03-30 2000-10-05 Jenapharm Gmbh Equileninderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6339078B1 (en) 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
US6326365B1 (en) 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
AU2005247948A1 (en) 2004-05-27 2005-12-08 Migenix Corp. 2-substituted 17-imino estrogen compounds for cytoprotection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626061A (en) * 1967-09-08 1971-12-07 Upjohn Co Compositions comprising 7{60 -methyl-17{60 -lkylated estradiols
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
DE4338314C1 (de) * 1993-11-10 1995-03-30 Jenapharm Gmbh Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen

Also Published As

Publication number Publication date
EP0753300B1 (de) 1999-09-22
JP2765822B2 (ja) 1998-06-18
GR3032191T3 (en) 2000-04-27
JPH09100292A (ja) 1997-04-15
EP0753300A1 (de) 1997-01-15
ATE184795T1 (de) 1999-10-15
DE59603130D1 (de) 1999-10-28
ES2138272T3 (es) 2000-01-01
DE19524937A1 (de) 1997-01-09

Similar Documents

Publication Publication Date Title
DE3751845D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung
DE9219084U1 (de) Zubereitung zur stetigen und kontrollierten Abgabe von medikamentösen Substanzen
FI935306A0 (fi) Anvaendning av renade, ytmodifierande aemnen foer att hindra aggregation av partiklar under sterilisation
DE59007178D1 (de) Verwendung alkylierter Polyethylenimine als gallensäureadsorbierende Arzneimittel sowie pharmazeutische Präparate.
DK0753300T3 (da) Anvendelse af steroider med antioxidative egenskaber til fremstilling af farmaceutiske præparater til medikamentøs substitu
DE69323538T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von Wärmeschäden beim Menschen und bei warmblütigen Säugetieren
DE69320242T2 (de) Medizinische Selbstklebefolie und Arzneimittelzubereitung
DK0744957T3 (da) Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A
DE69726007D1 (de) Prodrogs und analoga von camptothecin und deren verwendung als arzneimittel
DK0443224T3 (da) Anvendelse af thrombospondin til fremskyndelse af sårheling
BR9205642A (pt) Composiçao farmacêutica, compreendo pelo menos uma quinona, e composiçao para fabricaçao de medicamento
DE4494713T1 (de) Arylsulfonamidderivate und diese Derivate enthaltende Arzneimittel
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
DE59409205D1 (de) Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
DE69920418D1 (de) Arzneimittel gegen hepatitis
FI972949A (fi) Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmenetelmiä
DE69706241T2 (de) Pharmazeutische Zusammensetzung zur Behandlung der Leukämie enthaltend 9-cis-Retinoinsäure-alpha-Tocopherolester
EP0914826A4 (en) HEALING ACCELERATORS
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
ATE189395T1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
DE69327074T2 (de) Substituierte 1,2,4-Triazine-3,5-Dion Derivate und diese enthaltende Arzneimittel, insbesondere zur Behandlung von Coccidiose
DE69310565T2 (de) Verwendung von Bilobalid und deren Derivate zur Behandlung von Infektionen bei Menschen und für eine solche Anwendung geeignete pharmazeutische Zusammensetzung
ATE232738T1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
DE69128385D1 (de) Gummizusammensetzung und -gegenstand für Arzneimittel und medizinische Behandlungssysteme